DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
64.24
-1.02 (-1.56%)
At close: Mar 13, 2026, 4:00 PM EDT
64.58
+0.34 (0.53%)
After-hours: Mar 13, 2026, 7:59 PM EDT
DexCom Employees
DexCom had 11,100 employees as of December 31, 2025. The number of employees increased by 800 or 7.77% compared to the previous year.
Employees
11,100
Change (1Y)
800
Growth (1Y)
7.77%
Revenue / Employee
$420,000
Profits / Employee
$75,342
Market Cap
24.72B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 11,100 | 800 | 7.77% |
| Dec 31, 2024 | 10,300 | 700 | 7.29% |
| Dec 31, 2023 | 9,600 | 2,000 | 26.32% |
| Dec 31, 2022 | 7,600 | 600 | 8.57% |
| Dec 31, 2021 | 7,000 | 600 | 9.38% |
| Dec 31, 2020 | 6,400 | 1,200 | 23.08% |
| Dec 31, 2019 | 5,200 | 1,300 | 33.33% |
| Dec 31, 2018 | 3,900 | 910 | 30.43% |
| Dec 31, 2017 | 2,990 | 690 | 30.00% |
| Dec 31, 2016 | 2,300 | 791 | 52.42% |
| Dec 31, 2015 | 1,509 | 448 | 42.22% |
| Dec 31, 2014 | 1,061 | 296 | 38.69% |
| Dec 31, 2013 | 765 | 67 | 9.60% |
| Dec 31, 2012 | 698 | 78 | 12.58% |
| Dec 31, 2011 | 620 | 100 | 19.23% |
| Dec 31, 2010 | 520 | 135 | 35.06% |
| Dec 31, 2009 | 385 | 81 | 26.64% |
| Dec 31, 2008 | 304 | 52 | 20.63% |
| Dec 31, 2007 | 252 | -8 | -3.08% |
| Dec 31, 2006 | 260 | 105 | 67.74% |
| Dec 31, 2005 | 155 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Koninklijke Philips | 65,340 |
| GE HealthCare Technologies | 54,000 |
| Smith & Nephew | 18,060 |
| STERIS | 17,787 |
| Zimmer Biomet Holdings | 17,000 |
| Edwards Lifesciences | 16,000 |
| Bio-Rad Laboratories | 7,450 |
| Globus Medical | 6,000 |
DXCM News
- 4 days ago - Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026 - Business Wire
- 11 days ago - DexCom: Gaining Favor, With Useful Tailwinds To Support It Even Further - Seeking Alpha
- 13 days ago - DexCom, Inc. (DXCM) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript - Seeking Alpha
- 17 days ago - Dexcom Appoints Rick Osterloh to Board of Directors - Business Wire
- 17 days ago - HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 18 days ago - Dexcom Announces Upcoming Conference Presentation - Business Wire
- 4 weeks ago - DexCom, Inc. (DXCM) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - DexCom Reports Better-Than-Expected Q4 Results: Details - Benzinga